Boeing directors increase stakes as Wall Street maintains optimism

Buckley now holds a total of 10,250 shares, and Mollenkopf holds 6,717 shares. These open-market acquisitions, unlike typical grants or awards, suggest a belief in the company’s future prospects. Insider buying is generally interpreted as a positive signal, indicating that executives anticipate the stock’s value will increase.

Despite a year-to-date decline of 20.1% and a 10.0% decrease over the past month, Wall Street remains largely bullish on Boeing. The consensus price target stands at $233.35, representing a 32.0% premium over Thursday’s opening price. Institutional investors hold a substantial 76.7% of the shares, and a review of 13F filings from June 30, 2026, shows a mixed but generally positive sentiment among tracked filers, with Appaloosa initiating a new stake of 800,000 shares and Viking Global remaining the largest holder with 3,274,825 shares.

The current price reflects expectations of a future recovery, as indicated by the forward price-to-earnings ratio of 51. Management anticipates free cash flow of approximately $3 billion in 2027, rising to $10 billion by 2029. CEO Kelly Ortberg described the timeline as a “one-year shift to the right from expectations.”

While the directors’ purchases and the analysts’ Buy ratings offer support for a bullish outlook, challenges remain, particularly regarding the increase in 737 production. Boeing is striving to stabilize output at 47 airplanes per month and is now projecting that 737 deliveries will fall short of its 500-delivery target. Ortberg noted difficulties in the production ramp-up. The gap between the current price and the consensus target may begin to close with demonstrable progress towards that production rate, potentially around the company’s program-level delivery update in January.